• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

ALI revenues decline in Q3

Article

ALI revenues decline in Q3Purchasing delays related to the year 2000 problem weighed down financial results at ultrasound miniPACS firm ALI Technologies. During its fiscal third quarter (end-June), ALI posted revenues of $3.7 million (U.S.), an

ALI revenues decline in Q3

Purchasing delays related to the year 2000 problem weighed down financial results at ultrasound miniPACS firm ALI Technologies. During its fiscal third quarter (end-June), ALI posted revenues of $3.7 million (U.S.), an increase of 7% over the same period in 1998, but a decrease of 22% from second-quarter 1999 (end-March). The company attributed the decrease to Y2K software conformance issues its clients are facing.

During the quarter, the company incurred a net loss of $178,302, and sustained a charge of $231,058 for restruct-uring costs related to its purchase of Olicon Imaging Systems (PNN 7/99). ALI reported that its integration of Olicon’s image management business is almost complete.

ALI also announced that two multimodality sites are in clinical operation under its introductory beta site pilot program (PNN 12/98), which will be completed in the fall. In addition, the Vancouver, BC-based company has purchase commitments for three additional multimodality systems from Pitt County Memorial Hospital in Greenville, NC, the University of California, Los Angeles’ Santa Monica Clinic in Santa Monica, CA, and the Texas Health System-Arlington Memorial South Medical Center in Dallas.

Recent Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.